Aptose Biosciences Inc. (APTOF)
OTCMKTS
· Delayed Price · Currency is USD
1.240
-0.070 (-5.34%)
Aug 15, 2025, 4:00 PM EDT
Aptose Biosciences Employees
Aptose Biosciences had 13 employees as of December 31, 2024. The number of employees decreased by 23 or -63.89% compared to the previous year.
Employees
13
Change (1Y)
-23
Growth (1Y)
-63.89%
Revenue / Employee
n/a
Profits / Employee
-$1,624,923
Market Cap
3.18M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
American Oncology Network | 1,914 |
Northwest Biotherapeutics | 25 |
CytoDyn | 13 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
Aptose Biosciences News
- 2 days ago - Aptose Reports Second Quarter 2025 Results - GlobeNewsWire
- 9 days ago - Aptose Enrollment is Open for 160 mg Dosing Cohort of Tuspetinib in Phase 1/2 TUSCANY Trial of Frontline Triple Drug Therapy - GlobeNewsWire
- 15 days ago - Aptose Selects Ernst & Young Global Limited as its New Independent Auditor and Calls Reconvened Meeting of its Shareholders - GlobeNewsWire
- 4 weeks ago - Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML - GlobeNewsWire
- 6 weeks ago - Aptose Upgraded to Trade on OTCQB Market - GlobeNewsWire
- 6 weeks ago - Aptose Announces Deferral of Interest Payment - GlobeNewsWire
- 2 months ago - Aptose and Hanmi Enter New Loan Agreement to Advance Development of Tuspetinib in Triplet Therapy for AML - GlobeNewsWire
- 2 months ago - Aptose Provides Corporate Updates - GlobeNewsWire